Lin Sun
- Nephrology top 0.1%
- Chronic Kidney Disease and Diabetes 56
- Renal Diseases and Glomerulopathies 21
- Dialysis and Renal Disease Management 20
- Clinical Biochemistry top 0.1%
- Advanced Glycation End Products research 22
- Cancer Research top 1%
- Molecular Biology top 1%
- Mitochondrial Function and Pathology 14
- Renal and related cancers 11
-
- Autophagy in Disease and Therapy 17
-
- Endoplasmic Reticulum Stress and Disease 12
- Co-authors
- Yashpal S. KanwarFuyou LiuLi XiaoSheldon ChenZheng DongMing ZhanMing YangPing Xie
- Journals
- Kidney International (11 papers)Current Medicinal Chemistry (10 papers)Renal Failure (7 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Lin Sun
199 papers receiving 9.5k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Nephrology 2.8k
- Clinical Biochemistry 1.3k
- Cancer Research 1.1k
- Molecular Biology 4.3k
- Pathology and Forensic Medicine 952
Countries citing papers authored by Lin Sun
This map shows the geographic impact of Lin Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Sun more than expected).
Fields of papers citing papers by Lin Sun
This network shows the impact of papers produced by Lin Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Sun. The network helps show where Lin Sun may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lin Sun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 20 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 4 | |
| 8 | 2020 | 21 | |
| 9 | 2020 | 23 | |
| 10 | 2020 | 16 | |
| 11 | 2019 | 21 | |
| 12 | 2019 | 3 | |
| 13 | 2018 | 57 | |
| 14 | AKI on CKD: heightened injury, suppressed repair, and the underlying mechanismsbreakdown → | 2017 | 322 |
| 15 | A Feedback Glucose Control Strategy for Type II Diabetes Mellitus | 2011 | 2 |
| 16 | 2011 | 12 | |
| 17 | [Metabolic syndrome and chronic kidney disease in a rural adult population of Hunan province, China]. | 2009 | 1 |
| 18 | 2006 | 1 | |
| 19 | Design of Aid Walking Mechanism for Inferior Limb Rehabilitationand it's Hydraulic System | 2006 | 2 |
| 20 | The study of pulmonary fibrosis in severe acute respiratory syndrome | 2005 | 1 |
About Lin Sun
Lin Sun is a scholar working on Nephrology, Clinical Biochemistry and Cancer Research, having authored 207 papers that have together received 9.6k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (56 papers), Advanced Glycation End Products research (22 papers), Renal Diseases and Glomerulopathies (21 papers), Dialysis and Renal Disease Management (20 papers), Autophagy in Disease and Therapy (17 papers), Mitochondrial Function and Pathology (14 papers), Endoplasmic Reticulum Stress and Disease (12 papers) and Renal and related cancers (11 papers). The work is most often cited by research in Nephrology (2.8k citations), Clinical Biochemistry (1.3k citations) and Cancer Research (1.1k citations). Lin Sun has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yashpal S. Kanwar, Fuyou Liu, Li Xiao, Sheldon Chen, Zheng Dong, Ming Zhan, Ming Yang, Ping Xie, Shikun Yang and Jun Wada. Their work appears in journals such as Kidney International, Current Medicinal Chemistry, Renal Failure, American Journal of Physiology-Renal Physiology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.